CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Biocept Inc  (BIOC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 
 

BIOC's Revenue Year on Year Growth by Quarter and Year

Biocept Inc's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
BIOC Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 1.29 - 0.08
III Quarter September - 1.05 0.16 0.01
II Quarter June - 0.66 0.08 0.02
I Quarter March 1.68 0.22 0.15 0.03
FY   1.68 3.22 0.39 0.14

Financial Statements
Biocept Inc's first quarter 2017 Revenue $ 1.68 millions BIOC's Income Statement
Biocept Inc's first quarter 2016 Revenue $ 0.22 millions Quarterly BIOC's Income Statement
BIOC's Growth by Division See BIOC's Growth by Segment

BIOC Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -99.71 %
III Quarter September - 556.25 % 1500 % -99.96 %
II Quarter June - 725 % 300 % -99.91 %
I Quarter March 665.03 % 46.67 % 400 % -99.87 %
FY   - 725.64 % 178.57 % -



BIOC Revenue Growth Comment
Biocept Inc achieved in the first quarter, above Company average Revenue surge of 665.03% year on year, to $ 1.68 millions.

Among companies who have reported first quarter results in the Medical Laboratories industry only one Company has achieved higher year on year Revenue results in the first quarter. While Biocept Inc' s Revenue doubling of 665.03% ranks overall at the positon no. 60 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #17
Overall #60
Revenue Y/Y Growth Statistics
High Average Low
1504.59 % 517.58 % -100 %
(Sep 30 2015)   (Dec 31 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BIOC's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BIOC's Competitors
Revenue Growth for Biocept Inc's Suppliers
Revenue Growth for BIOC's Customers

You may also want to know
BIOC's Annual Growth Rates BIOC's Profitability Ratios BIOC's Asset Turnover Ratio BIOC's Dividend Growth
BIOC's Roe BIOC's Valuation Ratios BIOC's Financial Strength Ratios BIOC's Dividend Payout Ratio
BIOC's Roa BIOC's Inventory Turnover Ratio BIOC's Growth Rates BIOC's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Acura Pharmaceuticals, Inc  1,112.95 %$ 1,112.946 millions
Sophiris Bio Inc.  920.00 %$ 920.000 millions
Tesaro, Inc.  900.98 %$ 900.977 millions
Biodelivery Sciences International Inc  869.67 %$ 869.671 millions
Innovus Pharmaceuticals, Inc.  865.70 %$ 865.697 millions
Biocept Inc  660.30 %$ 660.298 millions
Geovax Labs, Inc.  521.29 %$ 521.292 millions
Cytomx Therapeutics, Inc.  424.20 %$ 424.202 millions
Sientra, Inc.  409.11 %$ 409.109 millions
Sorrento Therapeutics, Inc.  393.32 %$ 393.320 millions
Bluebird Bio, Inc.  355.77 %$ 355.771 millions
Agenus Inc  352.36 %$ 352.365 millions